Diabetes Research and Clinical Practice
Volume 72, Issue 3 , Pages 292-297 , June 2006

Detection of ketonemia and its relationship with hyperglycemia in type 1 diabetic patients

Received 22 June 2005 ,Revised 4 October 2005 ,Accepted 14 October 2005.

References 

  1. Wallace TM, Meston NM, Gardner SG, Matthews DR. The hospital and home use of a 30-second hand-held blood ketone meter: guidelines for clinical practice. Diabetic Med. 2001;18(8):640–645
  2. Laffel L. Sick-day management. Endocrinol. Metab. North Am. 2000;29(4):707–723
  3. Harano Y, Kosugi K, Hyosu T, Suzuki M, Hidaka H, Kashiwagi A, et al. Ketone bodies as markers for type 1 (insulin-dependent) diabetes and their value in the monitoring of diabetes control. Diabetología. 1984;26:343–348
  4. Byrne HA, Tieszen KL, Hollis S, Dornan TL, New JP. Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care. 2000;23(4):500–503
  5. Diabetes Control and Complications Trial Research Group. Hypoglycemia in the diabetes control and complications trial. Diabetes. 1997;46:271–286
  6. Mitchell GA, Kassovska-Bratinova S, Boukaftane Y, Robert MF, Wang SP, Ashmarina L, et al. Medical aspects of ketone body metabolism. Clin. Invest. Med. 1995;18:193–216
  7. Nathan M, Singer DE, Hurxthal K, Goodson JD. The clinical informational value of the glycosylated hemoglobin assay. New Engl. J. Med. 1984;310:341–346
  8. Avignon A, Radauceanu A, Monnier L. Non-fasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care. 1997;20:1822–1826
  9. Rohlfing C, Hsiao-Meier R, England J, Tennill A, Goldstein D. Defining the relationship between plasma glucose and HbA1c. Analysis of glucose profiles and HbA1c in the diabetes control and complications trial. Diabetes Care. 2002;25:275–278
  10. Uchigata Y, Kawatahara M, Ohsawa M, Miura J, Okudaira M, Takaike H, et al. Characteristics and learning effects of the predictability of the self-monitored blood glucose level in children with type 1 diabetes. Diabetes Res. Clin. Pract. 2004;65(2):79–83
  11. Pecoraro RE, Koepsell TD, Chen MS, Lipsky BA, Belcher DW, Inui TS. Comparative clinical reliability of fasting plasma glucose and glycosylated hemoglobin in non-insulin-dependent diabetes mellitus. Diabetes Care. 1986;9:370–375
  12. Iori E, Calò L, Valbusa D, Ceolotto G, Milani M, Pengo V, et al. Diabetic ketosis activates lymphomonocyte-inducible nitric oxide synthase. Diabetic Med. 2002;19:777–783
  13. Baron AD. The coupling of glucose metabolism and perfusion in human skeletal muscle. The potential role of endothelium-derived nitric oxide. Diabetes. 1996;45(Suppl. 1):S105–S109
  14. Rouzaut A, Subira ML, de Miguel C, Domingo-de-Miguel E, Gonzalez A, Santiago E, et al. Co-expression of inducible nitric oxide synthase and arginases in different human monocyte subsets. Apoptosis regulated by endogenous NO. Biochim. Biophys. Acta. 1999;1451:319–333
  15. Vaquero PM, de Ibarra LS, Gaspar R, Obesso A, Sainz M, Parramón M, et al. Recent onset type 1 diabetes mellitus treated on an outpatient basis—evolution of glycemia, ketonemia and ketonuria during the first three days. J. Pediatr. Endocrinol. Metabol. 2004;17(Suppl. 3):559
  16. Ampudia-Blasco FJ, Parramón M. Practical recommendations for every-day life with continuous subcutaneous insulin infusion (CSII): usefulness of capillary blood ketone test. Avances en Diabetología. 2005;21:44–51
  17. Guerci B, Tubiana-Rufi N, Bauduceau B, Bresson R, Cuperlier A, Delcroix C, et al. Advantages to using capillary blood β-hydroxybutyrate determination for the detection and treatment of diabetic ketosis. Diabetes Metabol. 2005;31:401–406
  18. Fishbein HA. Diabetic ketoacidosis, hyperosmolar nonketotic coma, lactic acidosis and hypoglycemia. In:  Harris MI editors. Diabetes in America. Washington, DC: Department of Health and Human Services; 1985;p. 330–340
  19. M.P. Matta, V. Melki, S. Bessière-Lacombe, H. Hanaire-Broutin, What are capillary blood ketone levels in type 1 diabetic patients using CSII in normal conditions of insulin delivery? Diabetes Metab. 30 (6) (2004) 543–7; Erratum in: Diabetes Metab. 31 (2) (2005) 109.
  20. Samuelsson U, Ludvigsson J. When should determination of ketonemia be recommended?. Diabetes Technol. Ther. 2002;4:645–650
  21. Newton CA, Raskin P. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus clinical and biochemical differences. Arch. Int. Med. 2004;164:1925–1931
  22. Welch BJ, Zib I. Case study: diabetic ketoacidosis in type 2 diabetes: “look under the sheets”. Clin. Diabetes. 2004;22:198–200
  23. Guerci B, Benichou M, Floriot M, Bohme P, Fougnot S, Franck P, et al. Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients. Diabetes Care. 2003;26:1137–1141
  24. American Diabetes Association. Test of glycaemia in diabetes. Diabetes Care. 2004;27(Suppl. 1):S91–S93

PII: S0168-8227(05)00413-4

doi: 10.1016/j.diabres.2005.10.008

Diabetes Research and Clinical Practice
Volume 72, Issue 3 , Pages 292-297 , June 2006

Article Tools